Steripath Improves Economic and Clinical Outcomes by Reducing False-Positive Results for Sepsis, Study Reports
April 17, 2019
(Seattle – April 17, 2019) – In the latest peer-reviewed published study on the impact of decreasing blood culture contamination rates using Steripath® ISDD®, researchers at Massachusetts General Hospital, Harvard Medical School and Wing Tech Inc. have concluded that both clinical and economic outcomes can be significantly improved.